Integer (NYSE:ITGR – Get Rating) released its quarterly earnings results on Thursday. The medical equipment provider reported $0.87 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.05, Briefing.com reports. The business had revenue of $378.79 million during the quarter, compared to analyst estimates of $352.43 million. Integer had a return on equity […]
Integer (NYSE:ITGR – Get Rating) updated its FY23 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $4.00-4.30 for the period, compared to the consensus estimate of $4.13. The company issued revenue guidance of $1.47-1.50 billion, compared to the consensus revenue estimate of $1.49 billion. Analysts Set New Price Targets A […]
Integer (NYSE:ITGR – Get Rating) is scheduled to be releasing its earnings data before the market opens on Thursday, April 27th. Analysts expect Integer to post earnings of $0.82 per share for the quarter. Integer has set its FY23 guidance at $4.00-4.30 EPS.Persons interested in participating in the company’s earnings conference call can do so […]
Integer (NYSE:ITGR – Get Rating) and Yubo International Biotech (OTCMKTS:YBGJ – Get Rating) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations. Profitability This table compares Integer and Yubo International Biotech’s net […]
Knights of Columbus Asset Advisors LLC decreased its holdings in Integer Holdings Co. (NYSE:ITGR – Get Rating) by 1.1% during the 4th quarter, HoldingsChannel reports. The firm owned 24,821 shares of the medical equipment provider’s stock after selling 280 shares during the quarter. Knights of Columbus Asset Advisors LLC’s holdings in Integer were worth $1,699,000 […]